Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 29, 2026
TickeronGET DAILY SIGNALS
British American Tobacco (BTI) Delivers Steady H1 2026 Growth with +2.9% Revenue and +7.9% EPS

British American Tobacco (BTI) Delivers Steady H1 2026 Growth with +2.9% Revenue and +7.9% EPS

Key Takeaways

  • British American Tobacco reported its first-half 2026 (H1 2026) results on July 30, 2026, with group revenue up 2.9% on a constant-currency basis.
  • Adjusted diluted earnings per share (EPS, a measure of profit attributable to each share) rose 7.9%, supported by lower net finance costs and strong cash conversion.
  • New Category revenue climbed 18%, led by a 66% surge in Modern Oral nicotine products such as Velo.
  • Smoke-free products reached 19.8% of group revenue, up 160 basis points, as the company added 4.1 million smokeless consumers to reach 35 million in total.
  • Management raised full-year EPS guidance to the middle of its 5%–8% growth range while expecting revenue and operating profit near the lower end.
  • For more context, explore Major News, Today's Price Move, Price Targets, and Forecast on Tickeron's dedicated BTI pages.
  • You can also explore Trending AI Robots to discover automated trading strategies aligned with current market conditions.

Earnings Context and Why It Matters

British American Tobacco's H1 2026 report offers a progress check on its long-running pivot from traditional cigarettes toward a "smokeless" future. The company's New Category portfolio — nicotine pouches, vapour, and heated tobacco — is now central to its growth story, even as combustibles remain the primary cash engine. Investors watch these results closely because they reveal whether the transition is generating genuine profitability rather than simply top-line growth. The first half also carried added significance following a December 2025 trading update and a string of regulatory developments in key markets such as the United States. I also checked this using Tickeron’s AI Screener to see how BTI compares to others in the industry.

Reported Results

For the six months ended June 30, 2026, British American Tobacco delivered results in line with management's own expectations on a constant-currency basis. Group revenue rose 2.9%, while adjusted diluted EPS increased 7.9%. Adjusted operating profit grew 3.5%, and the group's operating margin expanded by 30 basis points to 43.7%, reflecting stronger New Category profitability and ongoing cost savings.

New Category revenue increased 18%, with Modern Oral (nicotine pouches) up 66%, driven by the continued success of the Velo brand, including Velo Plus. Vapour revenue rose 5.3%, supported by a recovering U.S. market, while heated products lagged as glo revenue declined roughly 12% amid inventory movements and competitive pressure. Combustibles revenue grew 2.1%, helped by strong pricing, even as volumes fell 4.7%.

Management raised its full-year EPS outlook to the middle of the 5%–8% guidance range while signaling that revenue and operating profit would land near the lower end of their ranges, partly reflecting a roughly 1% transactional foreign-exchange headwind.

Market Reaction and Investor Sentiment

Sentiment around BTI heading into and following the H1 2026 release has been shaped by the company's improving U.S. performance and the accelerating adoption of modern oral products. The results confirmed a return toward management's medium-term growth algorithm, which investors generally viewed as a stabilizing signal. At the same time, lingering concerns over heated-product weakness, slower-than-expected recovery in the Asia-Pacific, Middle East, and Africa (APMEA) region, and competitive pressure in the U.S. discount segment have tempered enthusiasm. The raised EPS outlook and reaffirmed commitment to a progressive dividend and £1.3 billion buyback provided a degree of support for income-focused shareholders.

Forward Outlook and Key Factors to Monitor

Management pointed to a second-half-weighted profit profile, driven by the phasing of New Category investments and the ramp-up of cost-saving initiatives under its Fit2Win program. The company now targets roughly £700 million in annualized savings by 2028, with about £500 million expected by 2027.

Investors should watch whether Modern Oral momentum, particularly Velo and the newly launched Velo Max, continues to accelerate. The phased U.S. rollout of new Vuse vapour flavours and the expansion of heated products such as glo Hilo and Hyper Pro+ will also be important indicators of New Category traction.

On the cost and balance-sheet side, the company expects net finance costs of about £1.65 billion for the year, an underlying tax rate of 24%–25%, and leverage moving toward its 2.0–2.5x adjusted net debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) target. A continued recovery in APMEA and the sustainability of U.S. combustibles pricing remain key swing factors for the second half and into 2027. From what I see, these elements will shape the trajectory in the quarters ahead.

Using AI Tools for Deeper Analysis

In my view, tools like Tickeron’s AI-powered platforms can add valuable perspective when reviewing results like these. I often turn to the AI Screener to scan for comparable names in the consumer staples space and spot technical setups that align with fundamental shifts. It helps surface ideas efficiently without replacing core research, and it has been useful for tracking how names like BTI stack up against peers on metrics such as momentum and volatility.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BTI

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Momentum Indicator for BTI turns negative, indicating new downward trend

BTI saw its Momentum Indicator move below the 0 level on November 17, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned negative. In 46 of the 78 cases, the stock moved further down in the following days. The odds of a decline are at 59%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BTI moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 37 similar instances where the indicator moved out of overbought territory. In 20 of the 37 cases, the stock moved lower in the following days. This puts the odds of a move lower at 54%.

The Moving Average Convergence Divergence Histogram (MACD) for BTI turned negative on November 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 25 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.

BTI moved below its 50-day moving average on November 19, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BTI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for BTI crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 21 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 52%.

Following a +1.75% 3-day Advance, the price is estimated to grow further. Considering data from situations where BTI advanced for three days, in 241 of 379 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

BTI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 151 of 292 cases where BTI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 52%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 9 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 54 (best 1 - 100 worst), indicating steady price growth. BTI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 71 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.709) is normal, around the industry mean (-7.297). P/E Ratio (20.817) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (1.415) is also within normal values, averaging (3.595). Dividend Yield (0.054) settles around the average of (0.060) among similar stocks. P/S Ratio (3.521) is also within normal values, averaging (2.780).

The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 57.21B. The market cap for tickers in the group ranges from 99 to 308.42B. PM holds the highest valuation in this group at 308.42B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -19%. For the same Industry, the average monthly price growth was -24%, and the average quarterly price growth was -35%. MO experienced the highest price growth at -5%, while XXII experienced the biggest fall at -56%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was 90%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 52
Price Growth Rating: 70
SMR Rating: 73
Profit Risk Rating: 71
Seasonality Score: 35 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a retailer of tobacco related products

Industry Tobacco

Industry
Tobacco
Address
Globe House
Phone
+44 2078451000
Employees
47797
Web
https://www.bat.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.